ABSTRACT

Recent research is leading to an ever-increasing range of investigative approaches whose aim is to achieve effective neuroprotective or neurorestorative treatment for individuals affected by Parkinson‘s disease. New directions under investigation reach beyond traditional pharmacological approaches to venture into innovative surgical methods, gene t

chapter 1|15 pages

James Parkinson

chapter 4|19 pages

Parkinson’s Disease: Where Are We?

chapter 12|17 pages

Alpha-Synuclein and Parkinson’s Disease

chapter 13|14 pages

Parkin and Its Role in Parkinson’s Disease

chapter 14|31 pages

Heredofamilial Parkinsonism

chapter 19|15 pages

Pain in Parkinson’s Disease

chapter 21|19 pages

Sleep Disorders in Parkinson’s Disease

chapter 22|13 pages

Visual Function in Parkinson’s Disease

chapter 26|19 pages

Urinary Dysfunction in Parkinson’s Disease

chapter 27|13 pages

Sexual Dysfunction

chapter 30|9 pages

Respiratory Dysfunction

chapter 31|15 pages

Depression in Parkinson’s Disease

chapter 32|13 pages

Anxiety and Parkinson’s Disease

chapter 33|71 pages

Dementia in Parkinson’s Disease

chapter 36|22 pages

Pathophysiology of the Motor Disorder

chapter 40|20 pages

Excitotoxicity in Parkinson’s Disease

chapter 41|24 pages

Inflammation

chapter 42|21 pages

Cell Death in Parkinson’s Disease

chapter 46|68 pages

Neuroleptic-Induced Movement Disorders

chapter 47|12 pages

The Placebo Effect in Parkinson’s Disease

chapter 49|23 pages

MR Imaging of Parkinsonism

chapter 50|13 pages

Clinical Batteries

chapter 51|23 pages

Rating Scales

chapter 53|9 pages

Amantadine

chapter 57|24 pages

Dopamine Agonists in Parkinson’s Disease

chapter 61|12 pages

Swallowing Function in Parkinson’s Disease

chapter 63|16 pages

Music Therapy for People with Parkinson’s

chapter 65|19 pages

Treatment of Early Parkinson’s Disease

chapter 66|12 pages

Moderate Parkinson’s Disease

chapter 67|23 pages

Management of Advanced Parkinson’s Disease

chapter 69|11 pages

Restorative Therapy in Parkinson’s Disease

chapter 70|49 pages

Gene Therapy for Parkinson’s Disease

chapter 75|15 pages

Economics of Parkinson’s Disease